nobiletin has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asamoto, M; Hokaiwado, N; Kuribayashi, M; Ogawa, K; Ogiso, T; Ohnishi, H; Okuyama, H; Shirai, T; Takahashi, S; Tujimura, K | 1 |
| Cheng, MY; Ge, H; Zhang, HQ | 1 |
2 other study(ies) available for nobiletin and Experimental Hepatoma
| Article | Year |
|---|---|
Inhibition of cell proliferation by nobiletin, a dietary phytochemical, associated with apoptosis and characteristic gene expression, but lack of effect on early rat hepatocarcinogenesis in vivo.
Topics: Animals; Antioxidants; Apoptosis; Cell Proliferation; Dietary Supplements; Flavones; Gene Expression Profiling; Humans; Liver Neoplasms, Experimental; Male; Rats; Rats, Inbred F344; Tumor Cells, Cultured | 2004 |
[Antitumor effects of nobiletin on Heps and its mechanism].
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Transformation, Neoplastic; Citrus; Female; Flavones; Humans; Interleukin-2; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred ICR; Plants, Medicinal; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2006 |